However, since anti-MBP antibodies have already been described in several other diseases such as multiple sclerosis, Parkinson's disease, rheumatoid arthritis or schizophrenia (24, 58, 60, 64, 65), it seems unlikely that they would be useful as specific biomarkers for the diagnosis of ASD. Here, MBP is linked to multiple sclerosis.